ArticleMolecular and clinical oncology2025

Enhanced efficacy of immune checkpoint inhibitors with OK-432 in malignant pleural mesothelioma: A case report.

Kazuki Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.